of a biological function for HLA-E, a nonclassical class Ib molecule.
The peptides bound in the groove of the mouse class Ib molecule Qa-1 are derived from the leader segments of the classical H-2D and H-2L proteins (Aldrich et al., 1994) . New findings reveal that HLA-E, the human homolog of Qa-1, also predominantly binds leader peptides originating from HLA-A, -B, -C, and -G proteins (Braud et al., 1997 (Braud et al., , 1998b Lee et al., 1998a) . Both Qa-1 and HLA-E demonstrate limited polymorphism, are broadly expressed in tissues, and require a functional TAP heterodimer for the assembly of class I leader peptides in the HLA-E or Qa-1 groove. Of note, neither Qa-1 nor HLA-E possess leader segments that are permissive for transport of these molecules to the cell surface, making them dependent upon the by-products of other classical class I polypeptides for their expression. While Qa-1 serves as a weak transplantation antigen and can be recognized by alloantigen-specific CTL, until now there has been no clues about the physiological role of a class 1b molecule capable of binding leader segments lectin interactions are not essential to the specificity.
The nonameric class I-derived peptides binding to Qa-1 and HLA-E demonstrate similar structural charackilling by NK cell clones expressing CD94/NKG2A recepteristics and have identical anchor residues at positions tors, in the presence or absence of neutralizing anti-2 (Met) and 9 (Leu). An analysis of the sequences of the CD94 monoclonal antibodies. Results from these experileader peptides of different human HLA class I alleles ments suggested that most, but not all, HLA-A, -B, -C, that are permissive or nonpermissive for binding HLA-E and -G transfectants were protected from killing by NK provided an obvious resolution to why some, but not cells using the CD94/NKG2A receptor. But there were all, class I transfectants of the 721.221 cell line are recogno obvious structural similarities in the extracellular donized by NK cells expressing CD94/NKG2A receptors. mains of the protective HLA-A, -B, -C, or -G alleles that While 721.221 cells do not express HLA-A, -B, -C, and -G mapped the CD94/NKG2A recognition site. This probgenes, these cells do possess immature HLA-E polypeptides in the cytoplasm, but not on the cell surface. When lem has now been resolved by investigations in search HLA-E indicates that it is more restrained, tailored to Trinchieri, G. (1989) . Adv. Immunol. 47, fit the hydrophobic peptides derived from the leader HLA-E to bind leader peptides with high specificity and affinity. The leader segments of HLA-A, -B, -C, and -G are remarkably conserved, particularly in the region containing the nonameric peptide permissive for HLA-E binding. These findings suggest a hitherto unappreciated role for the leader segments of polypeptides, beyond their function in protein translocation.
The capacity of HLA-E to preferentially bind leader segments of class I molecules provides a clever biological solution to explain how NK cells expressing essentially nonpolymorphic receptors can monitor the expression of class I molecules that are constantly undergoing genetic diversification. Essentially, HLA-E acts as the sentinel to reflect the global status of class I on the cell, detecting events that disrupt the synthesis or transport of conventional class I molecules. The beauty and elegance of the system is that it allows an invariant NK cell receptor to interact with a highly conserved ligand HLA-E, yet keep check on the highly polymorphic and rapidly diversifying class I genes. However, has this strategy gone unnoticed by pathogens? A potential counterattack measure would be to disrupt normal class Ia synthesis to avoid detection by T cells, yet produce pathogen-derived proteins with leader segments permissive for HLA-E binding to evade NK cell surveillance. While an attractive concept, perhaps this provides the rationale for the existence of NK cell receptors for both
